Patents Assigned to Medella Therapeutics Limited
  • ANTIBODIES AGAINST RAMP3
    Publication number: 20130189285
    Abstract: Isolated antibodies capable of binding a receptor activity modifying protein (RAMP) of CRLR receptor wherein the antibodies are of IgG, IgA or IgM isotype are provided, together with nucleic acid molecules encoding such antibodies, vectors comprising such nucleic acid molecules, host cells comprising such vectors, and methods of making the disclosed antibodies using such host cells. Also provided are compositions including the disclosed antibodies and methods of treating disorders, such as tumors, inflammatory disorders, cardiovascular disorders and osteoporosis, by administering such compositions.
    Type: Application
    Filed: February 7, 2013
    Publication date: July 25, 2013
    Applicant: MEDELLA THERAPEUTICS LIMITED
    Inventor: Medella Therapeutics Limited
  • Antibodies against RAMP3
    Patent number: 8389237
    Abstract: The present invention provides an isolated antibody capable of binding a receptor activity modifying protein (RAMP) of CRLR receptor which antibody is of IgG, IgA or IgM isotype.
    Type: Grant
    Filed: April 23, 2008
    Date of Patent: March 5, 2013
    Assignee: Medella Therapeutics Limited
    Inventors: Timothy Michael Skerry, Gareth Owain Richards
  • ANTIBODIES AGAINST RAMP3
    Publication number: 20100111932
    Abstract: The present invention provides an isolated antibody capable of binding a receptor activity modifying protein (RAMP) of CRLR receptor which antibody is of IgG, IgA or IgM isotype.
    Type: Application
    Filed: April 23, 2008
    Publication date: May 6, 2010
    Applicant: MEDELLA THERAPEUTICS LIMITED
    Inventors: Timothy Michael Skerry, Gareth Owen Richards